Mounjaro Savings Card: Eli Lilly Programs Explained

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Mounjaro, has demonstrated average weight loss of 20% in clinical trials for eligible patients. Many people discover that manufacturer savings programs come with hidden limits, income thresholds, and eligibility gaps that leave them paying full price anyway.

How Eli Lilly's Mounjaro Savings Card Works

Eli Lilly offers a copay assistance program designed to reduce out-of-pocket costs for insured patients filling Mounjaro prescriptions at participating pharmacies. The program typically caps savings at a specific dollar amount per prescription and requires verification of household income, insurance status, and enrollment in a manufacturer database. Patients with government insurance (Medicare, Medicaid) or no insurance often find themselves ineligible, and those without a participating pharmacy nearby face additional barriers.

The Mounjaro savings card does not apply to compounded versions of tirzepatide, meaning patients seeking lower-cost alternatives through 503A compounding pharmacies cannot stack any manufacturer assistance with compounded options. This design naturally directs patients toward brand-name inventory, even when compounded formulations deliver identical active ingredients at substantially lower starting prices.

Eligibility Restrictions That Exclude Many Patients

Manufacturer savings programs typically exclude patients with Medicare or Medicaid coverage, forcing seniors and low-income individuals to pay retail prices of $900+ per month for brand Mounjaro. Self-insured employees, those with high-deductible health plans, and uninsured patients face similar exclusions or find their copay savings capped at amounts that still leave hundreds of dollars in personal liability each month.

PlexusDx compounded tirzepatide injection eliminates these eligibility barriers entirely. The service accepts patients across all 50 states regardless of insurance status, with pricing that remains fixed at $249/month for the starting tier—no income verification, no database enrollment, and no hidden restrictions based on medication type or coverage category.

Compounded Tirzepatide as a Transparent Alternative

Licensed 503A compounding pharmacies manufacture tirzepatide under strict quality standards using identical pharmaceutical-grade raw materials and the same chemical structure as brand Mounjaro. The difference lies in cost structure: compounded formulations eliminate brand marketing, packaging variation, and manufacturer profit margins, allowing pharmacies to pass savings directly to patients without membership fees or insurance requirements.

PlexusDx partners exclusively with licensed 503A compounding pharmacies (never 503B facilities) to deliver compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan. This flat monthly pricing remains constant regardless of dose escalation—your dose may need to go up, but your price will not. All formulations are HSA and FSA eligible, and customers in all 50 states can access the medication without prior authorization delays or insurance denials.

Personalization Through Precision Peptide Genetic Testing

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The genetic test adds $99 after the first month of treatment and provides 150+ clinical insights tailored to your specific biology. This level of personalization helps patients avoid unnecessary dose escalations, switch to better-matched alternatives faster if needed, and understand why certain GLP-1 protocols may work better for their genetic profile than others—information that no savings card or standard pharmacy model can provide.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will Eli Lilly's Mounjaro savings card work with compounded tirzepatide?

No. Manufacturer assistance programs apply only to brand-name Mounjaro from Eli Lilly. Compounded tirzepatide from licensed 503A pharmacies operates outside this ecosystem, which is why PlexusDx offers transparent flat pricing without relying on manufacturer coupons or rebate programs.

Can I use my Medicare or Medicaid with PlexusDx compounded tirzepatide?

PlexusDx does not bill insurance directly; instead, all medications are priced as out-of-pocket cash options, which eliminates the insurance eligibility barriers that exclude many Medicare and Medicaid patients from manufacturer savings cards. You can submit receipts to your FSA or HSA for reimbursement if your account permits it.

Is compounded tirzepatide as effective as brand Mounjaro?

Compounded tirzepatide contains the identical active pharmaceutical ingredient manufactured by licensed 503A compounding pharmacies under strict quality standards. Clinical efficacy depends on the dose and individual response, not whether the tirzepatide came from Eli Lilly or a compounding pharmacy.

What happens if I need a higher dose—will my price increase?

No. PlexusDx pricing remains flat at $289/month for compounded tirzepatide injection regardless of dose level. Your dose may need to go up based on your clinical response, but your monthly price will not change, making long-term treatment costs predictable and transparent.

How does the Precision Peptide Genetic Test help with tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I switch between PlexusDx compounded tirzepatide and brand Mounjaro?

Yes, switching is medically safe because both contain identical tirzepatide. However, switching back to brand Mounjaro after using compounded tirzepatide typically means losing cost savings, since Mounjaro pricing remains substantially higher unless you qualify for Eli Lilly's savings card.

Related Reading

• Eli Lilly Mounjaro Coupon
• Eli Lilly Mounjaro
• Mounjaro Savings Card
• Eli Lilly Tirzepatide

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.